§ 13F · FUND PROFILE
Vivo Capital, LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $1242.7T (13F)Positions · 47Turnover · — · Q4Filed · Feb 13, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$73.1T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 13, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | TERN | Terns Pharmaceuticals Inc | 5.35M | $216.0T | 14.0% | −22% |
| 2 | CDTX | Cidara Therapeutics, Inc. | 957K | $211.3T | 13.7% | −27% |
| 3 | PRAX | Praxis Precision Medicines | 329K | $96.9T | 6.3% | +65% |
| 4 | COGT | Cogent Biosciences Inc | 2.40M | $85.2T | 5.5% | −14% |
| 5 | TRVI | Trevi Therapeutics Inc | 5.09M | $63.8T | 4.1% | ±0% |
| 6 | AVDL | Avadel Pharmaceuticals PLC | 2.68M | $57.8T | 3.7% | ±0% |
| 7 | CMPX | Compass Therapeutics Inc | 9.55M | $51.3T | 3.3% | ±0% |
| 8 | DYN | Dyne Therapeutics Inc | 2.61M | $51.1T | 3.3% | ±0% |
| 9 | ABVX | Abivax SA - ADR | 359K | $48.5T | 3.1% | ±0% |
| 10 | DBVT | DBV Technologies SA | 2.46M | $47.2T | 3.1% | +133% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE VIVO SIGNAL
AC read
Vivo Capital, LLC is a Other fund managing $1242708.2 trillion in assets. The fund runs a portfolio of 47 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q3 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed